ECONOMIC DEVELOPMENT CORPORATION OF SARASOTA COUNTY
Economic Development Corporation of Sarasota County is a government agency that develops the economy by helping businesses.
ECONOMIC DEVELOPMENT CORPORATION OF SARASOTA COUNTY
Industry:
Government Market Research Non Profit
Founded:
2004-01-01
Address:
Sarasota, Florida, United States
Country:
United States
Website Url:
http://www.edcsarasotacounty.com
Total Employee:
1+
Status:
Active
Contact:
+1-941-309-1200
Email Addresses:
[email protected]
Technology used in webpage:
Content Delivery Network Global Site Tag IPv6 Yoast WordPress SEO Plugin Google Maps US Privacy User Signal Mechanism YouTube Cloudflare Network Error Logging Cloudflare DNS Google Translate Widget
Similar Organizations
Jamaica Social Investment Fund
Jamaica Social Investment Fund is a government agency that invests in community development in Jamaica.
Municipal Water District of Orange County
Municipal Water District of Orange County is a government agency that provides solutions to water issues and resources planning services.
Will County Center for Economic Development
Will County Center for Economic Development provides programs and services to diversify the economy for businesses and government agencies.
Official Site Inspections
http://www.edcsarasotacounty.com Semrush global rank: 4.23 M Semrush visits lastest month: 2.78 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Economic Development Corporation of Sarasota County"
Cystic Fibrosis Therapeutics Market Size & Share | Analysis 2034
The global cystic fibrosis therapeutics market size was valued at USD 15.7 billion in 2024. The market is expected to grow from USD 18.1 billion in 2025 to USD 68.4 billion in 2034 at a โฆSee details»
Cystic Fibrosis Therapeutics Market Size, Share Report 2030
The global cystic fibrosis therapeutics market size was estimated at USD 10.3 billion in 2024 and is projected to reach USD 22.7 billion by 2030, growing at a CAGR of 14.2% from 2025 to 2030.See details»
US Cystic Fibrosis Therapeutics Market Forecast and Company โฆ
1 day ago The United States Cystic Fibrosis Therapeutics Market is set to grow from an estimated US$ 2.32 billion in 2024 to US$ 4.72 billion by 2033, with an 8.22% CAGR from โฆSee details»
Cystic Fibrosis Therapeutics Market Size to Touch $39.15 Bn by โฆ
Feb 6, 2025 The global cystic fibrosis therapeutics market expected to reach USD 39.15 billion by 2034, growing at a CAGR of 14.24% over the forecast period. In 2024, North America โฆSee details»
Cystic Fibrosis Therapeutics Market
Aug 21, 2025 From 2020 to 2025, sales witnessed significant growth, registering a CAGR of 12.4%. According to Future Market Insights, a market research and competitive intelligence โฆSee details»
Cystic-Fibrosis Therapeutics Market Size | CAGR of 9.0%
Market players operating in the Cystic Fibrosis Therapeutics Market should experience substantial growth opportunities due to growing global demand. Below is a selection of companies actively โฆSee details»
Cystic Fibrosis Therapeutics Market Size | Global Forecast
5 days ago Cystic Fibrosis Therapeutics Market Size, Share, Growth, And Industry Analysis by Type (CFTR, Mucolytics, PERT, Anti-infectives, Bronchodilators) by Downstream Industry โฆSee details»
Cystic Fibrosis Therapeutics Market Size, Trends, Growth Drivers ...
Jul 3, 2025 The Cystic Fibrosis Therapeutics Market is expected to reach USD 12.05 billion in 2025 and grow at a CAGR of 11.86% to reach USD 21.11 billion by 2030. AbbVie Inc., Gilead โฆSee details»
Cystic Fibrosis Therapeutics Market Size & Forecast to 2033
Advances in gene therapy, CFTR modulators, enhanced awareness, better diagnostic methods, regulatory approvals, growing healthcare investments, and growing patient access to cutting โฆSee details»
Cystic Fibrosis Therapeutics Market Size, Share & Growth | 2034
On the basis of drug class, the CFTR modulators segment dominated the global cystic fibrosis therapeutics market share in 2024. However, the others segment is anticipated to be the โฆSee details»
Cystic Fibrosis Therapeutics Market Size, Top Share, Forecast to โฆ
To improve the overall state of public health, a great number of healthcare organizations and medical institutes are working to raise knowledge about the treatment of cystic fibrosis.See details»
Global Cystic Fibrosis Therapeutics Market $24.3 Billion by 2033
Apr 3, 2025 The global market for cystic fibrosis therapeutics research report provides market size (Revenue $million 2023 to 2033), market share analysis, growth trends and forecast โฆSee details»
Cystic Fibrosis Therapeutics Market Size | Growth till 2033
According to the report, CFTR modulators accounted for the largest market share as they offer a highly targeted treatment approach. They address the root cause of CF at the molecular level, โฆSee details»
Breakthrough cystic fibrosis drug that extends life by decades โฆ
4 hours ago One of this year's coveted Lasker Awards went to three scientists who helped invent a life-saving treatment for cystic fibrosis, a genetic disease.See details»
Leading Pediatric Cystic Fibrosis Trials | Children's Hospital โฆ
2 days ago In 2024, the Pediatric Cystic Fibrosis (CF) Therapeutics Development Center at Childrenโs Hospital Colorado, in partnership with National Jewish Health, enrolled more โฆSee details»
Cystic Fibrosis Therapeutics Market Report 2025-2033: Trends, โฆ
Apr 30, 2025 The Cystic Fibrosis Therapeutics Market is expected to reach US$ 16.78 billion in 2033 from US$ 7.70 billion in 2024, with a CAGR of 9.04% from 2025 to 2033.See details»
Cystic Fibrosis Therapeutics Market Hit USD 25.4 Billion by 2033
Jan 20, 2025 Leading pharmaceutical companies are actively investing in research and development to introduce next-generation therapies. According to recent healthcare data, over โฆSee details»
Burkholderia cepacia complex: 11 years of surveillance in ... - PubMed
In order to know our reality, we refer to an epidemiological study in 64 CF patients during 11 years of surveillance, focusing on infections caused by Burkholderia species.See details»
Cystic fibrosis: Correction of a fatal disease - PNAS
20 hours ago The 2025 Lasker~DeBakey Clinical Medical Research Award has been given to Michael Welsh, Jesús (Tito) González, and Paul Negulescu for their key roles in developing a โฆSee details»
Mortality Rate Trends for Sickle Cell Disease and Cystic Fibrosis
3 days ago This cross-sectional study examines differences in mortality rate trends for sickle cell disease and cystic fibrosis in the US, highlighting disparities in treatment progress, cost, and โฆSee details»